PLUS1
[ADVERT]
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 8,710.00 | 8,696.00 | 8,698.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 19,468.2 | 2,864.2 | 178.5 | 48.8 | 134,928 |
Astrazeneca (AZN) News Headlines
Astrazeneca News
| Date | Time | Source | Headline |
|---|---|---|---|
| 21/9/2021 | 08:36 | ALNC |  AstraZeneca to invest USD360 million in Irish manufacturing facility |
| 21/9/2021 | 07:38 | DJN | AstraZeneca to Build $360 Million Manufacturing Plant in Dublin |
| 21/9/2021 | 07:00 | UKREG | AstraZeneca PLC AstraZeneca $360m Irish manufacturing investment |
| 20/9/2021 | 11:07 | ALNC | UPDATE: AstraZeneca notes positive test results for new cancer drugs |
| 20/9/2021 | 10:22 | ALNC | UPDATE: AstraZeneca reports positive test results for new cancer drugs |
| 20/9/2021 | 08:46 | ALNC | TOP NEWS: AstraZeneca says Enhertu breast cancer drug improves survival |
| 20/9/2021 | 07:48 | DJN | AstraZeneca's Enhertu Cancer Treatment Reduced Risk of Disease Progression.. |
| 20/9/2021 | 07:00 | UKREG | AstraZeneca PLC Enhertu reduced risk of disease progression by 72% |
| 17/9/2021 | 18:05 | DJN | AstraZeneca Sees Positive Results for Enhertu Trial |
| 17/9/2021 | 13:58 | ALNC | AstraZeneca sees positive result for Imfinzi in lung cancer patients |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |
